VON GIERKE'S DISEASE (GSD TYPE IA)

Clinical trials for VON GIERKE'S DISEASE (GSD TYPE IA) explained in plain language.

Never miss a new study

Get alerted when new VON GIERKE'S DISEASE (GSD TYPE IA) trials appear

Sign up with your email to follow new studies for VON GIERKE'S DISEASE (GSD TYPE IA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Gene therapy patients monitored for years in rare disease study

Disease control Completed

This study followed 12 adults with a rare genetic liver disorder (GSDIa) for 4 to 6 years after they received a single dose of an experimental gene therapy. The main goal was to check for any long-term safety issues from the treatment. Researchers also monitored whether the thera…

Matched conditions: VON GIERKE'S DISEASE (GSD TYPE IA)

Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

VON GIERKE'S DISEASE (GSD TYPE IA)

Get alerted when new VON GIERKE'S DISEASE (GSD TYPE IA) trials appear

Gene therapy patients monitored for years in rare disease study